Concepedia

Yujiro Ueda

YU

Statistics

Publications

9

Citations

166

H-Index

9

Active since

2016

Affiliations

Kagoshima University(Current)

Kagoshima City Hospital

Sasebo City General Hospital

Oita University

Saga-Ken Medical Centre Koseikan

Yujiro Ueda is an author at Kagoshima University specializing in oncology, medicine, and chemotherapy.

ORCID

Publications per year

2016–2024

9

Publications

9

Prostate-Specific Antigen Flare Phenomenon Induced by Abiraterone Acetate in Chemotherapy-Naive Patients With Metastatic Castration-Resistant Prostate Cancer

Yujiro Ueda, Nobuaki Matsubara, Ken‐ichi Tabata et al. · Clinical Genitourinary Cancer · 2016 · 33 citations

, , +17

A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study

Taiga Otsuka, Tsuyoshi Shirakawa, Mototsugu Shimokawa et al. · International Journal of Clinical Oncology · 2021 · 26 citations

, , +11

Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study)

Futa Koga, Yasunori Kawaguchi, Mototsugu Shimokawa et al. · Journal of Geriatric Oncology · 2021 · 21 citations

, , +15

C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel

Tsuyoshi Shirakawa, Akitaka Makiyama, Mototsugu Shimokawa et al. · Scientific Reports · 2023 · 18 citations · Full text

, , +16

Efficacy of second-line chemotherapy after treatment with gemcitabine plus nab-paclitaxel or FOLFIRINOX in patients with metastatic pancreatic cancer

Masaru Fukahori, Yoshinobu Okabe, Mototsugu Shimokawa et al. · Scientific Reports · 2023 · 17 citations · Full text

, , +13

1–5 of 9